NHS Greater Glasgow & Clyde Area Drug and Therapeutics Committee
Greater Glasgow and Clyde Medicines

Medicines Update

For all prescribers and health professionals both in primary care and the acute sector.

News and information blog from ADTC covering clinical topics for all sectors of the NHS.

All editions of PostScript (the previous name for Medicines Update) from 2011 onwards have been added to this site.  Click here for an index to all previous editions.  If you would like a copy of a previous edition, please contact  medicines.update@ggc.scot.nhs.uk

Vitamin D: updated resources

Posted: May 19, 2017.
Category - Medicines Update
Tagged with - Osteoporosis

NHSGGC Osteoporosis Strategy Group has produced a clinical guideline on the

Read More...

Mefenamic acid: price increase

Posted: May 19, 2017.
Category - Medicines Update
Tagged with - NSAIDs

The May Drug Tariff price for mefenamic acid has increased significantly. <...

Read More...

Bisphosphonates: Oral Health

Posted: May 19, 2017.
Category - Medicines Update
Tagged with - Osteoporosis

Oral Health Management of Patients at Risk of Medication-related Osteonecrosis of the Jaw– new guidance and the role of prescribers and dispensers   Patients who are taking anti-resorptive or anti-a...

Read More...

Warfarin and miconazole oral gel potential interaction

Posted: May 18, 2017.
Category - Medicines Update

In June 2016 the Medicines and Healthcare products Regulatory Agency (MHRA) highlighted the potentially serious clinical consequences of the interaction between miconazole oral gel and warfarin. As the Glasgow & Clyde Anticoagulant Service...

Read More...

Buprenorphine prescribing

Posted: May 05, 2017.
Category - Medicines Update
Tagged with - Opioids

The NHSGGC Substitute Prescribing Management Group has decided to change from Suboxone® (buprenorphine and naloxone) to generic single agent buprenorphine 0.4mg, 2mg and 8mg sublingual tablets across all Addiction servic...

Read More...

MHRA Updates March and April 2017

Posted: May 04, 2017.
Category - Medicines Update

Drug Safety Update (April 2017) includes: Valproate and neurodevelopmental...

Read More...

Adding hospital medicines to GP practice systems

Posted: May 04, 2017.
Category - Medicines Update

Within General Practice, it is beneficial to ensure that a patient's medicine record includes medicines that may be prescribed and supplied outwith the GP practice, such as the acute sector, community mental health teams. Examples of drugs...

Read More...

Hypoglycaemia treatment with sugary drinks

Posted: May 04, 2017.
Category - Medicines Update
Tagged with - Diabetes

In response to the forthcoming “Sugar Tax” levy on the production of sugary drinks, many manufacturers are significantly reducing the amount of sugar in their products. This has implications for diabetics who may use drinks, most co...

Read More...

Dabigatran: colour change

Posted: April 25, 2017.
Category - Medicines Update

The manufacturer of dabigatran (Pradaxa®) has written to healthcare professionals to advise that the colour of the capsule is being changed in a move that is likely to improve patient safety.   Dabig...

Read More...

Sacubitril / valsartan

Posted: April 25, 2017.
Category - Medicines Update
Tagged with - Guidelines Update

Heart MCN Key Message   All new initiations of sacubitril/valsartan must be discussed on an individual patient basis with a consultant with special interest in heart failure. For safety reasons, every patient commenced on...

Read More...